Key result
Bariatric surgery is linked to improved LV global longitudinal strain from 16.3% to 18.5% versus medical therapy.
Why the study?
Obesity is a risk factor for heart failure, and surgical treatment of obesity may help prevent heart failure.
Does bariatric surgery improve cardiac remodeling and function in adults with severe obesity and preserved LVEF compared to medical management?
Cohort (n=72)
No
Does bariatric surgery improve cardiac remodeling and function in adults with severe obesity and preserved LVEF compared to medical management?
Absolute Event Rate: 18.5% vs 20.3%
p-value: p=<0.05
Bariatric surgery significantly improves subclinical cardiac remodeling and function in severely obese patients with preserved LVEF, highlighting its potential to prevent obesity-related heart failure.
Bariatric surgery was associated with improved subclinical systolic function and reduced LV mass; hypothesis-generating for HF risk reduction, needs RCTs before practice change.
BACKGROUND: Obesity is a risk factor for heart failure. Surgical treatment of obesity may help prevent heart failure. OBJECTIVES: We examine the effect of bariatric surgery on cardiac remodeling and function in adults with preserved left ventricular (LV) ejection fraction. METHODS: ) and preserved LV ejection fraction (≥50%) who underwent bariatric surgery (biliopancreatic diversion with duodenal switch), and 34 individuals with obesity managed medically were included. Conventional echocardiography and speckle tracking echocardiography were obtained at baseline and 12-month follow-up. RESULTS: . Bariatric surgery led to marked weight reduction (percentage of total weight loss 36.7% ± 7.1%) and significant improvements in obesity-related metabolic conditions/comorbidities. Bariatric surgery was associated with a significant reduction in LV mass and LV hypertrophy (P < 0.001), improvement in LV diastolic function parameters (P < 0.01), and improvement in subclinical systolic function (LV global longitudinal strain, 16.3% ± 2.5% vs 18.5% ± 1.3%, P < 0.05). Preoperative abnormalities of subclinical cardiac function were highly prevalent (79%) and normalized in 70% of subjects after surgery. Subjects with obesity managed medically remain with a significant burden of comorbidities and a number (38%) worsened their subclinical systolic function during the follow-up (P < 0.05). CONCLUSIONS: Bariatric surgery may be an effective and safe way to prevent and/or reverse obesity-related cardiac abnormalities. Larger prospective studies are warranted to confirm these observations and determine their long-term clinical implications.
No takes yet. Share an insight, caveat, or question.
Piché et al. (2026) conducted a cohort in Severe obesity with preserved left ventricular ejection fraction (n=72). Bariatric surgery (biliopancreatic diversion with duodenal switch) vs. Medical management was evaluated on Left ventricular global longitudinal strain (LV GLS) (p=<0.05). Bariatric surgery significantly improved subclinical systolic function, increasing left ventricular global longitudinal strain from 16.3% to 18.5%, and reduced left ventricular mass compared to medical management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: